EVRYSDI
EVRYSDI
Approved
DIN Number
02514931
Drug Class
Human
Market Date
May 19, 2021
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02514931
AIG Number0162847001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M09AX10 RISDIPLAM
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationOral
AHFS Classification92:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RISDIPLAMActive
Strength: 0.75 MG / ML
Monograph: RISDIPLAM